PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Dec 7, 2011
Global Feature
Patent Reform and the Pharmaceutical Industry: From First-To-File To Post-Grant Review And Beyond
By Courtenay C. Brinckerhoff
The author discusses the major changes in US patent laws as a result of the recently signed patent-reform law and the implications for pharmaceutical companies.
Technical Perspective: Antibody Drug Conjugates
By Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Biosimilars' Technology Needs
By Eric Langer
Biosimilar manufacturers need better expression systems and analytical tools to compete.
CSR and Sustainability Forum
Pharmaceutical Companies Target Green Manufacturing
A roundup of pharmaceutical companies' sustainability objectives and key projects.
World Health Organization Issues Progress Report on Combating HIV/AIDS
By Patricia Van Arnum
International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world.
CSR and Sustainability in the News
By Patricia Van Arnum
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other private and public organizations.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here